World Trade Center Health Program; Petition 012-Atherosclerosis; Finding of Insufficient Evidence, 90295-90297 [2016-29816]
Download as PDF
Federal Register / Vol. 81, No. 240 / Wednesday, December 14, 2016 / Proposed Rules
NAICS 1 code
Category
Industry
Industry
Industry
Industry
1 2012
..............
..............
..............
..............
Examples of potentially affected entities
447110, 447190 ......................................
454310 .....................................................
486910 .....................................................
493190 .....................................................
Fuel Retailers.
Other fuel dealers.
Natural gas liquids pipelines, refined petroleum products pipelines.
Other warehousing and storage—bulk petroleum storage.
North American Industry Classification System (NAICS).
This table is not intended to be
exhaustive, but rather provides a guide
for readers regarding entities likely to be
regulated by this action. This table lists
the types of entities that the EPA is now
aware could potentially be regulated by
this action. Other types of entities not
listed in the table could also be
regulated. To determine whether your
entity is regulated by this action, you
should carefully examine the
applicability criteria in the referenced
regulations. If you have any questions
regarding the applicability of this action
to a particular entity, consult the person
listed in the FOR FURTHER INFORMATION
CONTACT section.
B. What is the Agency’s authority for
taking this action?
This action is issued under the
authority of CAA sections 208, 211 and
301.
II. Request for Comment
A. Background
sradovich on DSK3GMQ082PROD with PROPOSALS
90295
In the Renewables Enhancement and
Growth Support (REGS) Rule,1 EPA is
proposing enhancements to its
Renewable Fuel Standards (RFS)
program and other related fuel
regulations to support market growth of
ethanol and other renewable fuels in the
U.S. These proposed changes will
provide the opportunity for increasing
the production and use of renewable
fuels by allowing the market to operate
in the most efficient and economical
way to introduce greater volumes of
renewable fuels under the program. The
proposed provisions for ethanol flex
fuel (EFF) 2 in the REGS rule would
provide additional flexibility to use
natural gasoline as an EFF blendstock
while maintaining the environmental
performance of these fuels. The use of
lower cost natural gasoline to make EFF
may reduce the price to consumers of
these fuels, thereby encouraging the use
of additional ethanol and furthering the
goals for the RFS program.
1 81
FR 80828, November 16, 2016.
the REGS rule, EPA is proposing that all EFF
blends that contain 16 to 83 volume percent ethanol
(E16–E83) would be subject to the same set of
regulatory controls rather than continuing to treat
E16–E50 blends as gasoline. E85 is a trade name
that has historically been used for blends that
contain 51 to 83 volume percent ethanol (E51–E83).
2 In
VerDate Sep<11>2014
16:32 Dec 13, 2016
Jkt 241001
B. Request for Comment
To support the use of natural gasoline
as an EFF blendstock while meeting the
EPA’s evaporative emission control and
public health protection goals, the EPA
proposed that a fuel volatility
compliance tool could be used to
demonstrate compliance with the
proposed volatility standards for EFF.
The proposed compliance tool was
based on a fuel volatility model that was
developed using data on the volatility of
gasoline—ethanol fuel blends.3 This
fuel volatility model, which is well
accepted by industry, is used to estimate
the volatility of ethanol blends made
with gasoline and/or blendstock for
oxygenate blending.4 At proposal, we
explained why we believed that the
proposed compliance tool would also be
a satisfactory means of estimating
ethanol blend volatility when natural
gasoline is used as a blendstock even
though we only had limited data that
evaluated its suitability for this purpose.
In sum, we reasoned that blendstock for
oxygenate blending and natural gasoline
blend linearly and would thus, behave
as a single component in compliance
tool calculations. The report that this
notice adds to the docket for the REGS
proposed rule, and for which we seek
public comment, contains the results of
a test program that compares empirical
data on E51–83 blend volatility when
natural gasoline is used as a blendstock
to the volatility estimated by the
proposed compliance tool.5 These test
data in this report indicate that the
proposed compliance tool may
significantly underestimate the
volatility of some higher level ethanol
blends when natural gasoline is used as
a blendstock. These data, therefore,
contradict the assumption that
blendstock for oxygenate blending and
natural gasoline blend linearly and
behave as a single component in
3 SAE technical paper 2007–01–4006, ‘‘A Model
for Estimating Vapor Pressures of Commingled
Ethanol Fuels,’’ Sam R. Reddy. See the discussion
in Section IV.F.3. of the REGS proposed rule
beginning on page 81 FR 80867.
4 A blendstock for oxygenate blending (BOB) is
formulated to manufacture compliant gasoline after
the addition of ethanol.
5 Property Analysis of Ethanol—Natural
Gasoline—BOB Blends to Make Flex Fuel, National
Renewable Energy Laboratory (NREL) technical
report 5400–67243, November 2016.
PO 00000
Frm 00041
Fmt 4702
Sfmt 4702
compliance tool calculations. The report
also suggests that other aspects of the
final blend may need to be taken into
account for the compliance tool to
provide a satisfactory estimate of
ethanol blend volatility when natural
gasoline is used as a blendstock. The
EPA requests comment on all aspects of
this report and the proposed fuel
volatility compliance tool as well as
how it might be modified to better
estimate the effect of natural gasoline on
the volatility of ethanol fuel blends. The
EPA will consider the information
contained in the report made available
by this notice and the resulting public
comments from this notice in
developing a final rule from the REGS
proposed rule.
Dated: December 1, 2016.
Christopher Grundler,
Director, Office of Transportation and Air
Quality.
[FR Doc. 2016–29896 Filed 12–13–16; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
42 CFR Part 88
[NIOSH Docket 094]
World Trade Center Health Program;
Petition 012—Atherosclerosis; Finding
of Insufficient Evidence
Centers for Disease Control and
Prevention, HHS.
ACTION: Denial of petition for addition of
a health condition.
AGENCY:
On April 11, 2016, the
Administrator of the World Trade
Center (WTC) Health Program received
two petitions (combined into Petition
012) to add atherosclerosis to the List of
WTC-Related Health Conditions (List).
The Program conducted a literature
search for the term in response to the
Petition and found no relevant studies
regarding atherosclerosis among 9/11exposed populations. Accordingly, the
Administrator finds that insufficient
evidence exists to request a
recommendation of the WTC Health
Program Scientific/Technical Advisory
Committee (STAC), to publish a
proposed rule, or to publish a
SUMMARY:
E:\FR\FM\14DEP1.SGM
14DEP1
90296
Federal Register / Vol. 81, No. 240 / Wednesday, December 14, 2016 / Proposed Rules
determination not to publish a proposed
rule.
DATES: The Administrator of the WTC
Health Program is denying this petition
for the addition of a health condition as
of December 14, 2016.
FOR FURTHER INFORMATION CONTACT:
Rachel Weiss, Program Analyst, 1090
Tusculum Avenue, MS: C–46,
Cincinnati, OH 45226; telephone (855)
818–1629 (this is a toll-free number);
email NIOSHregs@cdc.gov.
SUPPLEMENTARY INFORMATION:
Table of Contents
A. WTC Health Program Statutory Authority
B. Petition 012
C. Review of Scientific and Medical
Information and Administrator
Determination
D. Administrator’s Final Decision on
Whether To Propose the Addition of
Atherosclerosis to the List
E. Approval To Submit Document to the
Office of the Federal Register
sradovich on DSK3GMQ082PROD with PROPOSALS
A. WTC Health Program Statutory
Authority
Title I of the James Zadroga 9/11
Health and Compensation Act of 2010
(Pub. L. 111–347, as amended by Pub.
L. 114–113), added Title XXXIII to the
Public Health Service (PHS) Act,1
establishing the WTC Health Program
within the Department of Health and
Human Services (HHS). The WTC
Health Program provides medical
monitoring and treatment benefits to
eligible firefighters and related
personnel, law enforcement officers,
and rescue, recovery, and cleanup
workers who responded to the
September 11, 2001, terrorist attacks in
New York City, at the Pentagon, and in
Shanksville, Pennsylvania (responders),
and to eligible persons who were
present in the dust or dust cloud on
September 11, 2001, or who worked,
resided, or attended school, childcare,
or adult daycare in the New York City
disaster area (survivors).
All references to the Administrator of
the WTC Health Program
(Administrator) in this notice mean the
Director of the National Institute for
Occupational Safety and Health
(NIOSH) or his or her designee.
Pursuant to section 3312(a)(6)(B) of
the PHS Act, interested parties may
petition the Administrator to add a
health condition to the List in 42 CFR
88.1. Within 90 days after receipt of a
petition to add a condition to the List,
1 Title XXXIII of the PHS Act is codified at 42
U.S.C. 300mm to 300mm-61. Those portions of the
James Zadroga 9/11 Health and Compensation Act
of 2010 found in Titles II and III of Public Law 111–
347 do not pertain to the WTC Health Program and
are codified elsewhere.
VerDate Sep<11>2014
16:32 Dec 13, 2016
Jkt 241001
the Administrator must take one of the
following four actions described in
section 3312(a)(6)(B) and 42 CFR 88.17:
(1) Request a recommendation of the
STAC; (2) publish a proposed rule in the
Federal Register to add such health
condition; (3) publish in the Federal
Register the Administrator’s
determination not to publish such a
proposed rule and the basis for such
determination; or (4) publish in the
Federal Register a determination that
insufficient evidence exists to take
action under (1) through (3) above.
However, in accordance with 42 CFR
88.17(a)(4), the Administrator is
required to consider a new petition for
a previously-evaluated health condition
determined not to qualify for addition to
the List only if the new petition presents
a new medical basis—evidence not
previously reviewed by the
Administrator—for the association
between 9/11 exposures and the
condition to be added.
In addition to the regulatory
provisions, the WTC Health Program
has developed policies to guide the
review of submissions and petitions 2
and the analysis of evidence supporting
the potential addition of a non-cancer
health condition to the List.3 In
accordance with the aforementioned
non-cancer health condition addition
policy, the Administrator directs the
WTC Health Program to conduct a
review of the scientific literature to
determine if the available scientific
information has the potential to provide
a basis for a decision on whether to add
the health condition to the List. A
literature review includes a search for
peer-reviewed, published epidemiologic
studies (including direct observational
studies in the case of health conditions
such as injuries) about the health
condition among 9/11-exposed
populations; such studies are
considered ‘‘relevant.’’ Relevant studies
identified in the literature search are
further reviewed for their quantity and
quality to provide a basis for deciding
whether to propose adding the health
condition to the List. Where the
available evidence has the potential to
provide a basis for a decision, the
scientific and medical evidence is
further assessed to determine whether a
2 See WTC Health Program [2014], Policy and
Procedures for Handling Submissions and Petitions
to Add a Health Condition to the List of WTCRelated Health Conditions, May 14, https://
www.cdc.gov/wtc/pdfs/WTCHPPPPetitionHandling
Procedures14May2014.pdf.
3 See WTC Health Program [2016], Policy and
Procedures for Adding Non-Cancer Conditions to
the List of WTC-Related Health Conditions, May 11,
https://www.cdc.gov/wtc/pdfs/WTCHP_PP_Adding_
NonCancer_Conditions_Revision_11_May_
2016.pdf.
PO 00000
Frm 00042
Fmt 4702
Sfmt 4702
causal relationship between 9/11
exposures and the health condition is
supported. A health condition may be
added to the List if peer-reviewed,
published, direct observational or
epidemiologic studies provide
substantial support 4 for a causal
relationship between 9/11 exposures
and the health condition in 9/11exposed populations. If the evidence
assessment provides only modest
support 5 for a causal relationship
between 9/11 exposures and the health
condition, the Administrator may then
evaluate additional peer-reviewed,
published epidemiologic studies,
conducted among non-9/11-exposed
populations, evaluating associations
between the health condition of interest
and 9/11 agents.6 If that additional
assessment establishes substantial
support for a causal relationship
between a 9/11 agent or agents and the
health condition, the health condition
may be added to the List.
B. Petition 012
On April 11, 2016, the Administrator
received a petition from a New York
City Police Department (NYPD)
responder who worked at Ground Zero,
and a second, related petition which
requested the addition of
‘‘atherosclerosis (plaque in arteries),’’
and ‘‘atherosclerosis—arterial plaque,’’
respectively, to the List; the petitions
provided references to the same medical
basis, a study by Mani et al. [2013]. The
petitions together are considered
Petition 012 as permitted by 42 CFR
88.17(a)(3).7
In accordance with WTC Health
Program policy, the medical basis for a
potential addition to the List may be
demonstrated by reference to a peerreviewed, published, epidemiologic
study about the health condition among
9/11-exposed populations or to clinical
case reports of health conditions in
WTC responders or survivors.8 Both of
4 The substantial evidence standard is met when
the Program assesses all of the available, relevant
information and determines with high confidence
that the evidence supports its findings regarding a
causal association between the 9/11 exposure(s) and
the health condition.
5 The modest evidence standard is met when the
Program assesses all of the available, relevant
information and determines with moderate
confidence that the evidence supports its findings
regarding a causal association between the 9/11
exposure(s) and the health condition.
6 9/11 agents are chemical, physical, biological, or
other agents or hazards reported in a published,
peer-reviewed exposure assessment study of
responders or survivors who were present in the
New York City disaster area, at the Pentagon site,
or at the Shanksville, Pennsylvania site, as those
locations are defined in 42 CFR 88.1.
7 See Petition 012, WTC Health Program: Petitions
Received, https://www.cdc.gov/wtc/received.html.
8 See supra note 2.
E:\FR\FM\14DEP1.SGM
14DEP1
Federal Register / Vol. 81, No. 240 / Wednesday, December 14, 2016 / Proposed Rules
the submissions considered in the
current petition, Petition 012, presented
the same single reference to support the
request to add ‘‘Atherosclerosis (plaque
in arteries)’’ to the List. The reference,
a study by Mani et al. [2013],9 is a pilot
study of the ability of diagnostic
imaging to evaluate differences in
atherosclerosis profiles in WTC
responders exposed to high levels (as
found in the initial dust cloud) and low
levels (found after September 13, 2001)
of particulate matter. The study
evaluated the feasibility of using
dynamic contrast enhanced MRI, a
relatively new imaging method, to
evaluate atherosclerosis among 31 law
enforcement personnel who responded
at Ground Zero (19 with self-reported
high exposures and 12 with selfreported low exposures). The study
population examined in Mani et al.
[2013] is small and is not fully
representative of the greater 9/11
population, including other non-law
enforcement responders and survivors.
Although the study has attributes of an
epidemiologic study, the small subset of
law enforcement personnel sampled and
the non-random manner in which the
sample was obtained prevent
extrapolation of the findings of Mani et
al. [2013] to the whole 9/11-exposed
population. Moreover, the study does
not investigate the causal link between
9/11 exposures and atherosclerosis.
Therefore, the Administrator has
determined that while the inclusion of
this peer-reviewed and published study
in the submissions provides sufficient
medical basis to be considered a valid
petition, Mani et al. [2013] is not an
epidemiologic study, cannot be
considered relevant, and is not further
reviewed below.
sradovich on DSK3GMQ082PROD with PROPOSALS
C. Review of Scientific and Medical
Information and Administrator
Determination
In response to Petition 012, and
pursuant to Program policy,10 the
Program conducted a review of the
scientific literature on atherosclerosis to
determine if the available evidence has
the potential to provide a basis for a
decision on whether to add
atherosclerosis to the List.11 The
literature search identified one citation
for atherosclerosis; 12 upon review,
9 Mani V, Wong S, Sawit S, et al. [2013],
Relationship between Particulate Matter Exposure
and Atherogenic Profile in ‘‘Ground Zero’’ Workers
as Shown by Dynamic Contrast Enhanced MR
Imaging, Int J Cardiovasc Imaging 29:827–833.
10 Supra note 3.
11 Databases searched include: CINAHL, Embase,
PsycINFO, PubMed, and Scopus.
12 Landrigan PJ, Wright RO, Cordero JF, et al.
[2015], The NIEHS Superfund Research Program:
VerDate Sep<11>2014
16:32 Dec 13, 2016
Jkt 241001
however, it was found not to be relevant
because it was not a study of
atherosclerosis among the 9/11-exposed
population.
Since the literature review did not
identify any relevant studies of
atherosclerosis in the 9/11-exposed
population, in accordance with the
Program policy discussed above, the
Program was unable to further evaluate
Petition 012.
D. Administrator’s Final Decision on
Whether To Propose the Addition of
Atherosclerosis to the List
Finding no relevant studies with
regard to Petition 012, the Administrator
has accordingly determined that
insufficient evidence is available to take
further action at this time, including
either proposing the addition of
atherosclerosis to the List (pursuant to
PHS Act, sec. 3312(a)(6)(B)(ii) and 42
CFR 88.17(a)(2)(ii)) or publishing a
determination not to publish a proposed
rule in the Federal Register (pursuant to
PHS Act, sec. 3312(a)(6)(B)(iii) and 42
CFR 88.17(a)(2)(iii)). The Administrator
has also determined that requesting a
recommendation from the STAC
(pursuant to PHS Act, sec.
3312(a)(6)(B)(i) and 42 CFR
88.17(a)(2)(i)) is unwarranted.
For the reasons discussed above, the
request made in Petition 012 to add
atherosclerosis to the List of WTCRelated Health Conditions is denied.
Studies have not yet demonstrated
whether 9/11 exposures, including
inhalational dust/debris exposures or
psychological exposures of the duration
and magnitude experienced on and in
the aftermath of September 11, 2001,
could cause the development of
atherosclerosis in an individual WTC
responder or survivor several years
later. The Administrator looks forward
to more definitive studies that directly
evaluate the causal association between
9/11 exposures, especially inhalational
dust exposures, and atherosclerosis.
E. Approval To Submit Document to the
Office of the Federal Register
The Secretary, HHS, or her designee,
the Director, Centers for Disease Control
and Prevention (CDC) and
Administrator, Agency for Toxic
Substances and Disease Registry
(ATSDR), authorized the undersigned,
the Administrator of the WTC Health
Program, to sign and submit the
25 Years of Translational Research for Public
Health, Environ Health Perspect 123(10):909–918.
This manuscript describes the successes of the
Superfund Research Program; although the key
terms ‘‘atherosclerosis’’ and ‘‘World Trade Center’’
are both mentioned, they are not discussed in
relation to each other.
PO 00000
Frm 00043
Fmt 4702
Sfmt 4702
90297
document to the Office of the Federal
Register for publication as an official
document of the WTC Health Program.
Thomas R. Frieden, M.D., M.P.H.,
Director, CDC, and Administrator,
ATSDR, approved this document for
publication on December 2, 2016.
Dated: December 8, 2016.
John Howard,
Administrator, World Trade Center Health
Program and Director, National Institute for
Occupational Safety and Health, Centers for
Disease Control and Prevention, Department
of Health and Human Services.
[FR Doc. 2016–29816 Filed 12–13–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
50 CFR Part 17
[Docket No. FWS–HQ–ES–2016–0076;
4500030115]
RIN 1018–BB33
Endangered and Threatened Wildlife
and Plants; Listing Determinations for
Five Poecilotheria Tarantula Species
From Sri Lanka
Fish and Wildlife Service,
Interior.
ACTION: Proposed rule.
AGENCY:
We, the U.S. Fish and
Wildlife Service (Service), announce a
proposal to list the following five
tarantula species under the Endangered
Species Act of 1973, as amended (Act):
Poecilotheria fasciata, P. ornata, P.
smithi, P. subfusca, and P. vittata. This
document also serves as the 12-month
finding on a petition to list these
species. After review of the best
available scientific and commercial
information, we find that listing each of
these species is warranted and propose
listing all of them as endangered
species.
SUMMARY:
We will accept comments
received or postmarked on or before
February 13, 2017. Comments submitted
electronically using the Federal
eRulemaking Portal (see ADDRESSES
below) must be received by 11:59 p.m.
Eastern Time on the closing date. We
must receive requests for public
hearings, in writing, at the address
shown in FOR FURTHER INFORMATION
CONTACT by January 30, 2017.
ADDRESSES: You may submit comments
by one of the following methods:
(1) Electronically: Go to the Federal
eRulemaking Portal: https://
www.regulations.gov. In the Search box,
DATES:
E:\FR\FM\14DEP1.SGM
14DEP1
Agencies
[Federal Register Volume 81, Number 240 (Wednesday, December 14, 2016)]
[Proposed Rules]
[Pages 90295-90297]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-29816]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
42 CFR Part 88
[NIOSH Docket 094]
World Trade Center Health Program; Petition 012--Atherosclerosis;
Finding of Insufficient Evidence
AGENCY: Centers for Disease Control and Prevention, HHS.
ACTION: Denial of petition for addition of a health condition.
-----------------------------------------------------------------------
SUMMARY: On April 11, 2016, the Administrator of the World Trade Center
(WTC) Health Program received two petitions (combined into Petition
012) to add atherosclerosis to the List of WTC-Related Health
Conditions (List). The Program conducted a literature search for the
term in response to the Petition and found no relevant studies
regarding atherosclerosis among 9/11-exposed populations. Accordingly,
the Administrator finds that insufficient evidence exists to request a
recommendation of the WTC Health Program Scientific/Technical Advisory
Committee (STAC), to publish a proposed rule, or to publish a
[[Page 90296]]
determination not to publish a proposed rule.
DATES: The Administrator of the WTC Health Program is denying this
petition for the addition of a health condition as of December 14,
2016.
FOR FURTHER INFORMATION CONTACT: Rachel Weiss, Program Analyst, 1090
Tusculum Avenue, MS: C-46, Cincinnati, OH 45226; telephone (855) 818-
1629 (this is a toll-free number); email NIOSHregs@cdc.gov.
SUPPLEMENTARY INFORMATION:
Table of Contents
A. WTC Health Program Statutory Authority
B. Petition 012
C. Review of Scientific and Medical Information and Administrator
Determination
D. Administrator's Final Decision on Whether To Propose the Addition
of Atherosclerosis to the List
E. Approval To Submit Document to the Office of the Federal Register
A. WTC Health Program Statutory Authority
Title I of the James Zadroga 9/11 Health and Compensation Act of
2010 (Pub. L. 111-347, as amended by Pub. L. 114-113), added Title
XXXIII to the Public Health Service (PHS) Act,\1\ establishing the WTC
Health Program within the Department of Health and Human Services
(HHS). The WTC Health Program provides medical monitoring and treatment
benefits to eligible firefighters and related personnel, law
enforcement officers, and rescue, recovery, and cleanup workers who
responded to the September 11, 2001, terrorist attacks in New York
City, at the Pentagon, and in Shanksville, Pennsylvania (responders),
and to eligible persons who were present in the dust or dust cloud on
September 11, 2001, or who worked, resided, or attended school,
childcare, or adult daycare in the New York City disaster area
(survivors).
---------------------------------------------------------------------------
\1\ Title XXXIII of the PHS Act is codified at 42 U.S.C. 300mm
to 300mm-61. Those portions of the James Zadroga 9/11 Health and
Compensation Act of 2010 found in Titles II and III of Public Law
111-347 do not pertain to the WTC Health Program and are codified
elsewhere.
---------------------------------------------------------------------------
All references to the Administrator of the WTC Health Program
(Administrator) in this notice mean the Director of the National
Institute for Occupational Safety and Health (NIOSH) or his or her
designee.
Pursuant to section 3312(a)(6)(B) of the PHS Act, interested
parties may petition the Administrator to add a health condition to the
List in 42 CFR 88.1. Within 90 days after receipt of a petition to add
a condition to the List, the Administrator must take one of the
following four actions described in section 3312(a)(6)(B) and 42 CFR
88.17: (1) Request a recommendation of the STAC; (2) publish a proposed
rule in the Federal Register to add such health condition; (3) publish
in the Federal Register the Administrator's determination not to
publish such a proposed rule and the basis for such determination; or
(4) publish in the Federal Register a determination that insufficient
evidence exists to take action under (1) through (3) above. However, in
accordance with 42 CFR 88.17(a)(4), the Administrator is required to
consider a new petition for a previously-evaluated health condition
determined not to qualify for addition to the List only if the new
petition presents a new medical basis--evidence not previously reviewed
by the Administrator--for the association between 9/11 exposures and
the condition to be added.
In addition to the regulatory provisions, the WTC Health Program
has developed policies to guide the review of submissions and petitions
\2\ and the analysis of evidence supporting the potential addition of a
non-cancer health condition to the List.\3\ In accordance with the
aforementioned non-cancer health condition addition policy, the
Administrator directs the WTC Health Program to conduct a review of the
scientific literature to determine if the available scientific
information has the potential to provide a basis for a decision on
whether to add the health condition to the List. A literature review
includes a search for peer-reviewed, published epidemiologic studies
(including direct observational studies in the case of health
conditions such as injuries) about the health condition among 9/11-
exposed populations; such studies are considered ``relevant.'' Relevant
studies identified in the literature search are further reviewed for
their quantity and quality to provide a basis for deciding whether to
propose adding the health condition to the List. Where the available
evidence has the potential to provide a basis for a decision, the
scientific and medical evidence is further assessed to determine
whether a causal relationship between 9/11 exposures and the health
condition is supported. A health condition may be added to the List if
peer-reviewed, published, direct observational or epidemiologic studies
provide substantial support \4\ for a causal relationship between 9/11
exposures and the health condition in 9/11-exposed populations. If the
evidence assessment provides only modest support \5\ for a causal
relationship between 9/11 exposures and the health condition, the
Administrator may then evaluate additional peer-reviewed, published
epidemiologic studies, conducted among non-9/11-exposed populations,
evaluating associations between the health condition of interest and 9/
11 agents.\6\ If that additional assessment establishes substantial
support for a causal relationship between a 9/11 agent or agents and
the health condition, the health condition may be added to the List.
---------------------------------------------------------------------------
\2\ See WTC Health Program [2014], Policy and Procedures for
Handling Submissions and Petitions to Add a Health Condition to the
List of WTC-Related Health Conditions, May 14, https://www.cdc.gov/wtc/pdfs/WTCHPPPPetitionHandlingProcedures14May2014.pdf.
\3\ See WTC Health Program [2016], Policy and Procedures for
Adding Non-Cancer Conditions to the List of WTC-Related Health
Conditions, May 11, https://www.cdc.gov/wtc/pdfs/WTCHP_PP_Adding_NonCancer_Conditions_Revision_11_May_2016.pdf.
\4\ The substantial evidence standard is met when the Program
assesses all of the available, relevant information and determines
with high confidence that the evidence supports its findings
regarding a causal association between the 9/11 exposure(s) and the
health condition.
\5\ The modest evidence standard is met when the Program
assesses all of the available, relevant information and determines
with moderate confidence that the evidence supports its findings
regarding a causal association between the 9/11 exposure(s) and the
health condition.
\6\ 9/11 agents are chemical, physical, biological, or other
agents or hazards reported in a published, peer-reviewed exposure
assessment study of responders or survivors who were present in the
New York City disaster area, at the Pentagon site, or at the
Shanksville, Pennsylvania site, as those locations are defined in 42
CFR 88.1.
---------------------------------------------------------------------------
B. Petition 012
On April 11, 2016, the Administrator received a petition from a New
York City Police Department (NYPD) responder who worked at Ground Zero,
and a second, related petition which requested the addition of
``atherosclerosis (plaque in arteries),'' and ``atherosclerosis--
arterial plaque,'' respectively, to the List; the petitions provided
references to the same medical basis, a study by Mani et al. [2013].
The petitions together are considered Petition 012 as permitted by 42
CFR 88.17(a)(3).\7\
---------------------------------------------------------------------------
\7\ See Petition 012, WTC Health Program: Petitions Received,
https://www.cdc.gov/wtc/received.html.
---------------------------------------------------------------------------
In accordance with WTC Health Program policy, the medical basis for
a potential addition to the List may be demonstrated by reference to a
peer-reviewed, published, epidemiologic study about the health
condition among 9/11-exposed populations or to clinical case reports of
health conditions in WTC responders or survivors.\8\ Both of
[[Page 90297]]
the submissions considered in the current petition, Petition 012,
presented the same single reference to support the request to add
``Atherosclerosis (plaque in arteries)'' to the List. The reference, a
study by Mani et al. [2013],\9\ is a pilot study of the ability of
diagnostic imaging to evaluate differences in atherosclerosis profiles
in WTC responders exposed to high levels (as found in the initial dust
cloud) and low levels (found after September 13, 2001) of particulate
matter. The study evaluated the feasibility of using dynamic contrast
enhanced MRI, a relatively new imaging method, to evaluate
atherosclerosis among 31 law enforcement personnel who responded at
Ground Zero (19 with self-reported high exposures and 12 with self-
reported low exposures). The study population examined in Mani et al.
[2013] is small and is not fully representative of the greater 9/11
population, including other non-law enforcement responders and
survivors. Although the study has attributes of an epidemiologic study,
the small subset of law enforcement personnel sampled and the non-
random manner in which the sample was obtained prevent extrapolation of
the findings of Mani et al. [2013] to the whole 9/11-exposed
population. Moreover, the study does not investigate the causal link
between 9/11 exposures and atherosclerosis. Therefore, the
Administrator has determined that while the inclusion of this peer-
reviewed and published study in the submissions provides sufficient
medical basis to be considered a valid petition, Mani et al. [2013] is
not an epidemiologic study, cannot be considered relevant, and is not
further reviewed below.
---------------------------------------------------------------------------
\8\ See supra note 2.
\9\ Mani V, Wong S, Sawit S, et al. [2013], Relationship between
Particulate Matter Exposure and Atherogenic Profile in ``Ground
Zero'' Workers as Shown by Dynamic Contrast Enhanced MR Imaging, Int
J Cardiovasc Imaging 29:827-833.
---------------------------------------------------------------------------
C. Review of Scientific and Medical Information and Administrator
Determination
In response to Petition 012, and pursuant to Program policy,\10\
the Program conducted a review of the scientific literature on
atherosclerosis to determine if the available evidence has the
potential to provide a basis for a decision on whether to add
atherosclerosis to the List.\11\ The literature search identified one
citation for atherosclerosis; \12\ upon review, however, it was found
not to be relevant because it was not a study of atherosclerosis among
the 9/11-exposed population.
---------------------------------------------------------------------------
\10\ Supra note 3.
\11\ Databases searched include: CINAHL, Embase, PsycINFO,
PubMed, and Scopus.
\12\ Landrigan PJ, Wright RO, Cordero JF, et al. [2015], The
NIEHS Superfund Research Program: 25 Years of Translational Research
for Public Health, Environ Health Perspect 123(10):909-918. This
manuscript describes the successes of the Superfund Research
Program; although the key terms ``atherosclerosis'' and ``World
Trade Center'' are both mentioned, they are not discussed in
relation to each other.
---------------------------------------------------------------------------
Since the literature review did not identify any relevant studies
of atherosclerosis in the 9/11-exposed population, in accordance with
the Program policy discussed above, the Program was unable to further
evaluate Petition 012.
D. Administrator's Final Decision on Whether To Propose the Addition of
Atherosclerosis to the List
Finding no relevant studies with regard to Petition 012, the
Administrator has accordingly determined that insufficient evidence is
available to take further action at this time, including either
proposing the addition of atherosclerosis to the List (pursuant to PHS
Act, sec. 3312(a)(6)(B)(ii) and 42 CFR 88.17(a)(2)(ii)) or publishing a
determination not to publish a proposed rule in the Federal Register
(pursuant to PHS Act, sec. 3312(a)(6)(B)(iii) and 42 CFR
88.17(a)(2)(iii)). The Administrator has also determined that
requesting a recommendation from the STAC (pursuant to PHS Act, sec.
3312(a)(6)(B)(i) and 42 CFR 88.17(a)(2)(i)) is unwarranted.
For the reasons discussed above, the request made in Petition 012
to add atherosclerosis to the List of WTC-Related Health Conditions is
denied.
Studies have not yet demonstrated whether 9/11 exposures, including
inhalational dust/debris exposures or psychological exposures of the
duration and magnitude experienced on and in the aftermath of September
11, 2001, could cause the development of atherosclerosis in an
individual WTC responder or survivor several years later. The
Administrator looks forward to more definitive studies that directly
evaluate the causal association between 9/11 exposures, especially
inhalational dust exposures, and atherosclerosis.
E. Approval To Submit Document to the Office of the Federal Register
The Secretary, HHS, or her designee, the Director, Centers for
Disease Control and Prevention (CDC) and Administrator, Agency for
Toxic Substances and Disease Registry (ATSDR), authorized the
undersigned, the Administrator of the WTC Health Program, to sign and
submit the document to the Office of the Federal Register for
publication as an official document of the WTC Health Program. Thomas
R. Frieden, M.D., M.P.H., Director, CDC, and Administrator, ATSDR,
approved this document for publication on December 2, 2016.
Dated: December 8, 2016.
John Howard,
Administrator, World Trade Center Health Program and Director, National
Institute for Occupational Safety and Health, Centers for Disease
Control and Prevention, Department of Health and Human Services.
[FR Doc. 2016-29816 Filed 12-13-16; 8:45 am]
BILLING CODE 4163-18-P